Literature DB >> 7896882

Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro.

I Västrik1, A Kaipainen, T L Penttilä, A Lymboussakis, R Alitalo, M Parvinen, K Alitalo.   

Abstract

Mad is a basic region helix-loop-helix leucine zipper transcription factor which can dimerize with the Max protein and antagonize transcriptional activation by the Myc-Max transcription factor heterodimer. While the expression of Myc is necessary for cell proliferation, the expression of Mad is induced upon differentiation of at least some leukemia cell lines. Here, the expression of the mad gene has been explored in developing mouse tissues. During organogenesis in mouse embryos mad mRNA was predominantly expressed in the liver and in the mantle layer of the developing brain. At later stages mad expression was detected in neuroretina, epidermis, and whisker follicles, and in adult mice mad was expressed at variable levels in most organs analyzed. Interestingly, in the skin mad was highly expressed in the differentiating epidermal keratinocytes, but not in the underlying proliferating basal keratinocyte layer. Also, in the gut mad mRNA was abundant in the intestinal villi, where cells cease proliferation and differentiate, but not in the crypts, where the intestinal epithelial cells proliferate. In the testis, mad expression was associated with the completion of meiosis and early development of haploid cells. In cell culture, Mad inhibited colony formation of a mouse keratinocyte cell line and rat embryo fibroblast transformation by Myc and Ras. The pattern of mad expression in tissues and its ability to inhibit cell growth in vitro suggests that Mad can cause the cessation of cell proliferation associated with cell differentiation in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896882      PMCID: PMC2120421          DOI: 10.1083/jcb.128.6.1197

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop.

Authors:  B R Stanton; A S Perkins; L Tessarollo; D A Sassoon; L F Parada
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

Review 2.  Myc and Max function as a nucleoprotein complex.

Authors:  E M Blackwood; L Kretzner; R N Eisenman
Journal:  Curr Opin Genet Dev       Date:  1992-04       Impact factor: 5.578

Review 3.  The role of c-myc in cell growth.

Authors:  G I Evan; T D Littlewood
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

4.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.

Authors:  T P Mäkelä; P J Koskinen; I Västrik; K Alitalo
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

6.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

Authors:  B Amati; S Dalton; M W Brooks; T D Littlewood; G I Evan; H Land
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

Review 7.  Role of myc amplification and overexpression in cell growth, differentiation and death.

Authors:  P J Koskinen; K Alitalo
Journal:  Semin Cancer Biol       Date:  1993-02       Impact factor: 15.707

8.  Oncogenic activity of the c-Myc protein requires dimerization with Max.

Authors:  B Amati; M W Brooks; N Levy; T D Littlewood; G I Evan; H Land
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Alternative mRNA forms and open reading frames of the max gene.

Authors:  I Västrik; P J Koskinen; R Alitalo; T P Mäkelä
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

View more
  28 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Essential role for Max in early embryonic growth and development.

Authors:  H Shen-Li; R C O'Hagan; H Hou; J W Horner; H W Lee; R A DePinho
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

3.  MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.

Authors:  A N Billin; A L Eilers; K L Coulter; J S Logan; D E Ayer
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineering.

Authors:  Giusy Della Gatta; Mukesh Bansal; Alberto Ambesi-Impiombato; Dario Antonini; Caterina Missero; Diego di Bernardo
Journal:  Genome Res       Date:  2008-04-25       Impact factor: 9.043

7.  Inhibition of cell proliferation by the Mad1 transcriptional repressor.

Authors:  M F Roussel; R A Ashmun; C J Sherr; R N Eisenman; D E Ayer
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  c-Myc promotes differentiation of human epidermal stem cells.

Authors:  A Gandarillas; F M Watt
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

9.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

10.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.